Studies have also shown that SAA reverses paclitaxel resistance in human breast cancer [50], reduces MMP-2 expression, and inhibits p-ERK protein expression in human nasopharyngeal carcinoma cells [51] and oral squamous cell carcinoma [52]. The gene discussed is MMP2; the disease is breast carcinoma.